Liver function tests were altered in all patients, the elevated bilirubin and serum glutamic oxaloacetic transaminase, serum glutamic-pyruvic transaminase
, and alkaline phosphatase (ALP) of all patients.
There was a significant derangement in serum glutamic-pyruvic transaminase
(SGPT) and serum glutamic-oxaloacetic transaminase (SGOT).
Serum was analyzed to compare the levels of albumin, globulin, total cholesterol, glutamic oxaloacetic transaminase (GOT), glutamic-pyruvic transaminase
(GPT), and blood urea nitrogen (BUN) using an automated blood analyzer (Sysmex, Seoul, Korea).
Variables Mean [+ or -] SD Glucose (mmoL/moL) 7.22 [+ or -] 2.0 Hemoglobin A1c (mmoL/moL) 59.4 [+ or -] 8.7 Hemoglobin A1c (%) 7.6 [+ or -] 0.8 Creatinine (mg/dL) 0.9 [+ or -] 0.2 Serum Glutamic-Pyruvic Transaminase
(U/L) 19.1 [+ or -] 7.3 Total Cholesterol (mmoL/moL) 4.79 [+ or -] 0.9 Triglyceride (mmoL/moL) 1.69 [+ or -] 0.8 High Density Lipoprotein-Cholesterol (mmoL/moL) 1.09 [+ or -] 0.3 Low Density Lipoprotein-Cholesterol (mmoL/moL) 3.32 [+ or -] 0.3 Table 3.
Laboratory investigation showed increased total bilirubin (13.64 mg/dl, normal: 0.2-1.2 mg/dl), direct bilirubin (6.63 mg/dl, normal: 0.0-0.2 mg/dl), serum glutamic oxaloacetic transaminase (3344 mg/dl, normal: 15-35 mg/dl), serum glutamic-pyruvic transaminase
(2224 mg/dl, normal: 5-45 mg/dl), raised INR, increased inflammatory markers with neutrophillic leukocytosis, increased lactate dehydrogenase, and decreased uric acid.
As expected, body temperature, creatinine, blood urea nitrogen (BUN), white blood cells (WBC), C-reactive protein (CRP), pH, lactate, glucose, lactate dehydrogenase, serum glutamic-oxaloacetic transaminase (SGOT), serum glutamic-pyruvic transaminase
(SGPT) (p<0.001) and [K.sup.+] (p=0.043) levels are higher in the sepsis group compared to the controls.
TC, TG, LDL, HDL, glutamic-pyruvic transaminase
(ALT), and glutamic oxalacetic transaminase (AST) levels were determined at the Biochemistry Study Institution, Affiliated Hospital of Ningxia Medical University (Ningxia, China).
The serum glutamic-oxaloacetic transaminase (GOT) and glutamic-pyruvic transaminase
(GPT) were measured by the IFCC method (Hitachi 917[R] device, Roche Diagnostics, Florida, USA).
Laboratory analysis showed the following: leukocytosis (total leukocyte count, 16,700 cells/[mm.sup.3]; segmented neutrophils, 80%); fasting blood sugar, 202 mg/dl; glycosylated hemoglobin (HbA1c), 12.8%; total bilirubin, 4.74mg/dl; direct bilirubin, 3.49 mg/dl; alkaline phosphatase, 553 U/L; serum glutamic-oxaloacetic transaminase (SGOT), 27 U/L; and serum glutamic-pyruvic transaminase
(SGPT), 39 U/L.